About The Rx Consultant

The Rx Consultant is a subscription-based service that delivers practical updates & reviews covering all the top-selling drugs and common health conditions. Our publications focus on the facts busy front-line pharmacists and other health care practitioners need to stay current, and provide it a streamlined, easy reading style.

Founded in 1991, The Rx Consultant has subscribers throughout the United States, Canada & The United Kingdom. For 27 years, pharmacists, nurse practitioners and pharmacy technicians have relied on The Rx Consultant for accurate, unbiased updates they can trust. We are completely independent of the pharmaceutical industry and has no commercial bias.

→ Visit The Rx Consultant

Rx Blog users - Save 40% on a subscription to
The Rx Consultant

Use Promo Code RXBLOG18

→ Subscribe Now

A connection between statins and the development of diabetes has been suspected following observational and long-term clinical studies. A recent study from The Netherlands provides more definitive information. Researchers followed 9535 individuals over 45 years old who did not have diabetes at baseline. Their median age was 64.3 years and 58% were women. The median follow-up period was 4 years. Compared with individuals who never took a statin, ever-statin users had a 38% higher risk of developing type 2 diabetes. Having a higher baseline fasting glucose and being overweight or obese were strong predictors of developing diabetes.

This study further supports a link between statin use and development of type 2 diabetes. When starting statins, advise providers to consider checking fasting glucose and calculating BMI. If elevated, measures to address them should be taken (eg, enrolling the in a weight loss program).

Ahmadizar F, et al. Br J Clin Pharmacol 2019;1-10

More News

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Share This